IP Library Granted Patent US 10,017,455
Granted Patent B2
US 10,017,455 · App. 15/619,290 · Granted Jul 10, 2018

Enhanced production of fatty acid derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,017,455
App. No.
15/619,290
Granted
Jul 10, 2018
Kind
B2
Abstract

Genetically engineered cells and microorganisms are provided that produce fatty alcohols from the fatty acid biosynthetic pathway, as well as methods of their use.

Claims (27)

1. A composition comprising fatty acid derivatives, wherein one or more of the fatty acid derivatives are fatty acid ethyl esters, and

wherein

the fatty acid ethyl esters are members selected from the group consisting of unsaturated fatty acid ethyl esters and saturated fatty acid ethyl esters, and

wherein

the unsaturated fatty acid ethyl esters have a double bond at position 7 in the carbon chain from the reduced end of the fatty acid ethyl ester, and

wherein

the unsaturated fatty acid ethyl esters are present in an amount that is at least 50% by weight of the composition.

2. The composition of claim 1 , wherein the unsaturated fatty acid ethyl esters are present in an amount that is at least 55% by weight of the composition.

3. The composition of claim 1 , wherein the unsaturated fatty acid ethyl esters are present in an amount that is at least 60% by weight of the composition.

4. The composition of claim 1 , wherein the unsaturated fatty acid ethyl esters are present in an amount that is at least 65% by weight of the composition.

5. The composition of claim 1 , wherein the unsaturated fatty acid ethyl esters are present in an amount that is at least 70% by weight of the composition.

6. The composition of claim 1 , wherein the unsaturated fatty acid ethyl esters are present in an amount that is at least 75% by weight of the composition.

7. The composition of claim 1 , wherein the unsaturated fatty acid ethyl esters are present in an amount that is at least 80% by weight of the composition.

8. The composition of claim 1 , wherein the unsaturated fatty acid ethyl esters are present in an amount that is at least 85% by weight of the composition.

9. The composition of claim 1 , wherein the unsaturated fatty acid ethyl esters are present in an amount that is at least 90% by weight of the composition.

10. The composition of claim 1 , wherein the unsaturated fatty acid ethyl esters are monounsaturated.

11. The composition of claim 1 , wherein one or more of the fatty acid ethyl esters are C 16 fatty acid ethyl esters, and

wherein

the composition comprises a percentage by weight of the C 16 fatty ethyl esters relative to total fatty esters of at least 30%.

12. The composition of claim 11 , wherein the composition comprises a percentage by weight of the C 16 fatty ethyl esters relative to total fatty esters of at least 40%.

13. The composition of claim 11 , wherein the composition comprises a percentage by weight of the C 16 fatty ethyl esters relative to total fatty esters of at least 50%.

14. The composition of claim 1 , wherein one or more of the fatty acid ethyl esters are C 18 fatty acid ethyl esters, and

wherein

the composition comprises a percentage by weight of the C 18 fatty ethyl esters relative to total fatty esters of at least 30%.

15. The composition of claim 14 , wherein the composition comprises a percentage by weight of the C 18 fatty ethyl esters relative to total fatty esters of at least 40%.

16. The composition of claim 14 , wherein the composition comprises a percentage by weight of the C 18 fatty ethyl esters relative to total fatty esters of at least 50%.

17. The composition of claim 1 , wherein the fatty acid derivatives include one or more fatty acid derivatives having a carbon chain that is 8:0, 10:0, 12:0, 14:0, 14:1, 16:0, 16:1, 18:0, 18:1, 18:2, 18:3, 20:0, 20:1, 20:2, 20:3, 22:0, 22:1 and 22:3 or a combination thereof.

Assignments (4)
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 050695/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2018
From: HU, ZHIHAO; VALLE, FERNANDO
To: REG LIFE SCIENCES, LLC
Reel/Frame 046020/0473 →